Dangerous deception--hiding the evidence of adverse drug effects

N Engl J Med. 2006 Nov 23;355(21):2169-71. doi: 10.1056/NEJMp068246.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antifibrinolytic Agents / adverse effects*
  • Aprotinin / adverse effects*
  • Deception
  • Drug Approval
  • Drug Industry*
  • Humans
  • Observation
  • Publication Bias*
  • Research Design

Substances

  • Antifibrinolytic Agents
  • Aprotinin